CONDUIT Lateral Lumbar Intervertebral Fusion Cage, CONDUIT Instruments
510(k) K223688
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK223688 | Date8 Mar 2023 | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 25 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- MAX
- FDA applicant
- Medos International Sàrl
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3080
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Conduit Lateral Lumbar Intervertebral Fusion Cage is a spinal implant designed for lateral lumbar interbody fusion. It is classified as an intervertebral cage intended to facilitate bone fusion between adjacent vertebrae in the lumbar spine, providing structural support and promoting bony integration.
This device is supplied as a sterile, single-use implant system, including both the fusion cage and associated instrumentation. It is intended for use in surgical settings where lateral lumbar interbody fusion procedures are performed, adhering to standard orthopedic surgical protocols. The device holds FDA 510(k) clearance under the Traditional 510(k) Review pathway and is compliant with the EU Medical Device Regulation (MDR).
Other devices from Medos International SARL
Questions
AI-generated answers, 18 Sep 2026
What types of spinal procedures is the CONDUIT™ Lateral Lumbar Intervertebral Fusion Cage specifically designed for?
The CONDUIT™ Lateral Lumbar Intervertebral Fusion Cage is designed exclusively for lateral lumbar interbody fusion procedures. This technique involves placing the cage between adjacent lumbar vertebrae from a lateral (side) approach to stabilize the spine, promote bone fusion, and restore structural integrity in the lumbar region.
Is the CONDUIT™ system intended for reuse in multiple surgeries, or is it meant to be used only once?
The CONDUIT™ Lateral Lumbar Intervertebral Fusion Cage and its associated instrumentation are supplied as a sterile, single-use system. This means each package is intended for one surgical procedure only, adhering to best practices for infection control and patient safety.
What regulatory pathways has the CONDUIT™ system undergone, and how does this affect its use?
The CONDUIT™ system holds FDA clearance under the Traditional 510(k) Review pathway, specifically classified as substantially equivalent (SESE) to a predicate device. It is also compliant with the EU Medical Device Regulation (MDR), ensuring it meets both U.S. and European standards for spinal fusion implants. This clearance confirms its adherence to safety and performance requirements for lateral lumbar interbody fusion procedures.
How is the CONDUIT™ system packaged and prepared for use in the operating room?
The CONDUIT™ system is supplied as a sterile, pre-packaged implant system, including both the fusion cage and the necessary instrumentation. This ensures readiness for immediate use in surgical settings, minimizing preparation time and maintaining sterility throughout the procedure.